Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

Carl Icahn Is Locked in Battle Against His Own Kind

Por: MarketWatch Business May 12, 2023

thumbnail

Activist investors have found themselves at the other side of the table before, but Icahn Enterprises is facing a short seller. Hindenburg isn’t rooting for Icahn Enterprises’ success, and hopes to profit from a continued decline in the stock. In recent years, funds run by activist investors Nelson Peltz, Dan Loeb, and Bill Ackman have also faced activists, but their attackers were looking to improve operations and move shares higher. Short... + full article



Similar News

Icahn vs. Illumina: The CEO’s Job—and Icahn’s Reputation—Are on the Line

MarketWatch USA Business May 25, 2023

thumbnailIllumina is holding its annual meeting at 1 p.m. Eastern time, at which the results of the proxy vote will be announced. The meeting will be held virtually, and is only open to shareholders. The stakes are high for Icahn, who needs a win. The Wall Street lion is facing an from a... + más

Biotech company Illumina pushes back against Carl Icahn’s proxy fight over $7.1 billion Grail deal | CNBC

Illumina ordered by FTC to unwind $7b Grail deal from 2021 | The Boston Globe


Icahn Enterprises continues to tumble following Hindenburg short report, Bill Ackman's responses

Associated Press USA Business May 25, 2023

thumbnailWASHINGTON (AP) — The business empire of corporate raider and activist investor continues to tumble amid the fallout following a recent report from short-selling firm Hindenburg Research — and losses are accelerating as a longtime rival echoes the firm’s allegations.In the... + más

Icahn Enterprises continues to tumble following Hindenburg short report, Bill Ackman's responses | ABC News

Activist investor Icahn becomes target of short seller | The Boston Globe


Icahn Enterprises continues to tumble following Hindenburg short report, Bill Ackman's responses

ABC News USA Business May 25, 2023

thumbnailWASHINGTON -- The business empire of corporate raider and activist investor Carl Icahn continues to tumble amid the fallout following a recent report from short-selling firm Hindenburg Research — and losses are accelerating as a longtime rival echoes the firm's... + más

Icahn Enterprises continues to tumble following Hindenburg short report, Bill Ackman's responses | Associated Press

Activist investor Icahn becomes target of short seller | The Boston Globe


Activist investor Carl Icahn's wealth plunged by $10 billion after a short-seller accused his company of running a 'Ponzi-like' structure

Business Insider USA Business May 03, 2023

thumbnailJump to 0 An icon in the shape of a person's head and shoulders. It often indicates a user profile. An icon in the shape of a person's head and shoulders. It often indicates a user profile. All Featured About Follow Subscriptions US Markets Loading... H M S In the news... + más

Hindenburg Research blasts Carl Icahn’s hedge fund as ‘Ponzi-like’ in latest short-seller campaign | New York Post

Biotech company Illumina pushes back against Carl Icahn’s proxy fight over $7.1 billion Grail deal | CNBC


Hindenburg Research blasts Carl Icahn’s hedge fund as ‘Ponzi-like’ in latest short-seller campaign

New York Post USA Business May 02, 2023

thumbnailBillionaire corporate raider Carl Icahn’s hedge fund has allegedly created a “Ponzi-like economic structure” that has falsely inflated the value of his investments, according to bombshell allegations from a prominent short-seller on Tuesday. Hindenburg Research — whose... + más

Activist investor Icahn becomes target of short seller | The Boston Globe

Activist investor Carl Icahn's wealth plunged by $10 billion after a short-seller accused his company of running a 'Ponzi-like' structure | Business Insider


Biotech company Illumina pushes back against Carl Icahn’s proxy fight over $7.1 billion Grail deal

CNBC USA Health March 21, 2023

thumbnailIn this articleCarl IcahnAdam Jeffery CNBC Biotech company pushed back Monday against Carl Icahn's proxy fight over the company's acquisition of cancer test developer Grail, saying the activist investor's board nominees do not add value. The San Diego-based DNA... + más

Carl Icahn claims Illumina directors got extra insurance to close 'disastrous' $7.1 billion Grail deal | CNBC

Icahn proposes three candidates for Illumina’s board — Here’s what could be next in the battle | CNBC


Sinking stocks have helped activist campaigns surge. But giants like Carl Icahn say the business is riskier than ever.

Business Insider USA Business December 14, 2022

thumbnailCarl Icahn had a textbook strategy for the Nevada-based energy utility Southwest Gas Holdings. The legendary activist investor purchased almost 5% of the company's shares in late 2021 and publicly , winning four of its 11 board seats, the ouster of its chief executive, and... + más

Carl Icahn says he still thinks we are in a bear market despite Thursday's rally | CNBC

Carl Icahn snaps up shares of canning giant Crown. Here’s how he may build value | CNBC



About iurex | Privacy Policy | Disclaimer |